Correction to: Myocardial Hyperemia via Cardiomyocyte Catabolism of β-Hydroxybutyrate

Key Points

• Myocardial hyperemia is influenced by the catabolism of β-hydroxybutyrate in cardiomyocytes, revealing a key metabolic pathway.
• The correction highlights the importance of accurate metabolic processes in understanding heart function.
• Observational analysis identifies the pathways involved in myocardial hyperemia, emphasizing their role in cardiomyocyte health.
• Understanding these metabolic pathways may suggest new therapeutic approaches for cardiac conditions.